List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Aged |
| 4 | Humans |
| 4 | Middle Aged |
| 3 | Chemotherapy |
| 3 | Female |
| 3 | Levodopa (adverse effects) |
| 3 | Male |
| 3 | Parkinson Disease (drug therapy) |
| 3 | Parkinson's disease |
| 2 | Administration, Oral |
| 2 | Dose-Response Relationship, Drug |
| 2 | Drug Therapy, Combination |
| 2 | Human |
| 2 | Levodopa (administration & dosage) |
| 2 | Neurologic Examination (drug effects) |
| 2 | Parkinson Disease (physiopathology) |
| 2 | Parkinson disease |
| 2 | Treatment |
| 2 | α2-Adrenergic receptor |
| 1 | Adrenergic alpha-Antagonists (adverse effects) |
| 1 | Adrenergic alpha-Antagonists (therapeutic use) |
| 1 | Adult |
| 1 | Age Factors |
| 1 | Agonist |
| 1 | Antagonist |
| 1 | Antiparkinson Agents (adverse effects) |
| 1 | Antiparkinson Agents (therapeutic use) |
| 1 | Antiparkinson agent |
| 1 | Atrophy (diagnosis) |
| 1 | Atrophy (physiopathology) |
| 1 | Blood flow |
| 1 | Brain (pathology) |
| 1 | Bromocriptine (administration & dosage) |
| 1 | Carbidopa (administration & dosage) |
| 1 | Cerebral Palsy (diagnosis) |
| 1 | Cerebral Palsy (physiopathology) |
| 1 | Cerebrovascular Circulation (drug effects) |
| 1 | Comparative study |
| 1 | Crossover study |
| 1 | Dextromethorphan (administration & dosage) |
| 1 | Dextromethorphan (adverse effects) |
| 1 | Diagnosis, Differential |
| 1 | Dopamine |
| 1 | Double blind study |
| 1 | Drug Administration Schedule |
| 1 | Dyskinesia |
| 1 | Dyskinesia, Drug-Induced (drug therapy) |
| 1 | Efaroxan |
| 1 | Healthy volunteers |
| 1 | Idazoxan |
| 1 | Idazoxan (adverse effects) |
| 1 | Idazoxan (therapeutic use) |
| 1 | Levodopa |
| 1 | Levodopa (therapeutic use) |
| 1 | L‐DOPA, dyskinesia |
| 1 | Motricity |
| 1 | Multiple system atrophy |
| 1 | N-Methylaspartate (antagonists & inhibitors) |
| 1 | N-Methylaspartate (physiology) |
| 1 | Nervous system diseases |
| 1 | Neuropsychological Tests |
| 1 | Normal |
| 1 | Parkinson Disease (diagnosis) |
| 1 | Parkinson Disease (psychology) |
| 1 | Phase II trial |
| 1 | Pilot Projects |
| 1 | Randomization |
| 1 | Receptors, N-Methyl-D-Aspartate (drug effects) |
| 1 | Receptors, N-Methyl-D-Aspartate (physiology) |
| 1 | Reflex, Vestibulo-Ocular |
| 1 | Regional Blood Flow (drug effects) |
| 1 | Regional blood flow |
| 1 | Single photon emission computed tomography |
| 1 | Supranuclear ophthalmoplegia |
| 1 | Supranuclear palsy |
| 1 | Tomography, Emission-Computed |
| 1 | Vestibuloocular reflex cancellation |
| 1 | idazoxan |
| 1 | α2 receptors |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "J. L. Montastruc"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "J. L. Montastruc" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= J. L. Montastruc
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
